NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jiksak Bioengineering, Inc.

Jiksak Bioengineering, Inc.

Private
KawasakiHealthcare & Life Scienceshttps://www.jiksak.co.jp/

Last Round

Series B

Aug 29, 2022

Total Funding Raised

$7.39M

Company Overview

Jiksak Bioengineering, Inc. is a biotechnology company that develops therapies for intractable neurodegenerative and neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

nerve organoiddrug discoverydisease modelingneurodegenerative diseasesregenerative medicinetargeted drug deliveryorganoid platform3D nerve tissueiPSC technologydrug delivery platformCRO servicespreclinical modelsamyotrophic lateral sclerosisALSnerve repair3D cell cultureDrug-Linked CarrierDLC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jiksak Bioengineering, Inc. Comparables

Compare Jiksak Bioengineering, Inc. with similar companies based on industry and business-model similarity.

Jiksak Bioengineering, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuCyte
81%
28bio
81%
MicroBrain Biotech
81%

Jiksak Bioengineering, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 29, 2022
Series BMar 23, 2021
Early FundingFeb 21, 2018

Key People

Founding team and executive leadership

Jiro Kawada

Co-Chief Executive Officer

Executive Team

Nori Yumoto

Co-Chief Executive Officer

Executive Team

Takahara Hiroumi

Chief Financial Officer

Executive Team

Jiksak Bioengineering, Inc. Investors

Notable investors and investment history

Jiksak Bioengineering, Inc. investors
InvestorRounds
CEJ CapitalSeries B
ANRI株式会社Series B, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 162% MoM to 3.1K.

  • Feb 25, 2025

    Monthly visitors grew 214% MoM, reaching 6.9K.

Jiksak Bioengineering, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jiksak Bioengineering, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jiksak Bioengineering, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKawasaki
Employee Range10
Year Founded2017
Last FundingAug 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.